Cannabinoid compositions for treatment of post-traumatic epilepsy
A cannabinoid composition of CBD, CBG, and THC addresses the inadequacies of current PTE treatments by reducing seizures and improving quality of life through a combination of botanical drug substances, extracts, and terpenes, providing effective relief for refractory and drug-resistant cases.
AU2024403831A1Pending Publication Date: 2026-07-23BIOPHARMACEUTICAL RESEARCH COMPANY
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- AU · AU
- Patent Type
- Applications
- Current Assignee / Owner
- BIOPHARMACEUTICAL RESEARCH COMPANY
- Filing Date
- 2024-12-20
- Publication Date
- 2026-07-23
Abstract
Cannabinoid compositions formulated for use in the treatment of post-traumatic epilepsy (PTE) are disclosed. The compositions include cannabidiol (CBD), cannabigerol (CBG), and tetrahydrocannabinol (THC) as the major components therein, which may be isolated, purified or extracted from cultivars and blended together. The compositions include CBD, CBG and THC in certain ratios, formulated for the use in the treatment of PTE.
Need to check novelty before this filing date? Find Prior Art